- Home
- NCPL vs ALBT Comparison
NCPL vs ALBT Comparison
Compare NCPL & ALBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NCPL | ALBT |
|---|---|---|
| Founded | 1984 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1M | 5.9M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | NCPL | ALBT |
|---|---|---|
| Price | $0.79 | $1.23 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 16.5M | 182.6K |
| Earning Date | 12-15-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $797,839.00 | ★ $1,611,940.00 |
| Revenue This Year | $739.37 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.62 | $0.88 |
| 52 Week High | $8.75 | $11.66 |
Technical Indicators
Market Signals| Indicator | NCPL | ALBT |
|---|---|---|
| Relative Strength Index (RSI) | 38.50 | 44.29 |
| Support Level | $0.77 | $0.88 |
| Resistance Level | $0.96 | $1.40 |
| Average True Range (ATR) | 0.24 | 0.19 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 12.74 | 42.81 |
Price Performance
Historical ComparisonAbout NCPL Netcapital Inc.
Netcapital Inc is a financial technology company. The company facilitates the growth of private companies by providing fundraising services and other consulting services. The company's online private investment platform connects entrepreneurs and investors, enabling companies to raise capital digitally. The Company operates in a single operating segment, which is the provision of fintech services.
About ALBT Avalon GloboCare Corp.
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment, which is the key revenue driver, and the laboratory testing services segment. The company focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.